Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chai Ge Tui Re Granules for Common Cold with Exterior Cold and Interior Heat Pattern
CTR20190168Phase 2Active
- Sponsor
- Beijing Kaijin Technology
- Start
- Jan 2019
- Countries
- 1
01
Overview
A Phase 2 trial of Chaigetuire Keli in upper respiratory infection (URI), sponsored by Beijing Kaijin Technology. Started Jan 2019; status: active.
02
Drugs
Chaigetuire Keli
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20190168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190168.